Prostate Cancer Clinical Trial
A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX
Summary
This is a multi-center, prospective, observational study of patients being treated with ORGOVYX. The goal of this study is to generate real-world evidence about the safety and effectiveness of ORGOVYX in patients with prostate cancer in routine clinical care and the clinical course during treatment with and following cessation of ORGOVYX.
Full Description
This prospective observational cohort study will be conducted in patients who are initiating treatment or have initiated treatment with ORGOVYX within the 1 month prior to the time of study enrollment and who remain on treatment at the time of enrollment. The decision to initiate treatment with ORGOVYX should be made prior to study enrollment. The study is designed to better understand the actual experience of patients with prostate cancer treated with ORGOVYX by collecting data on treatment patterns, adherence, and selective safety data. Additionally, a better understanding of the trajectory of patients with prostate cancer following cessation of ORGOVYX therapy will be gained by observing the clinical course of the disease, health outcomes, and health-related quality-of-life (HRQoL) in these patients.
Eligibility Criteria
Inclusion Criteria:
Patients who are diagnosed with prostate cancer and initiating treatment with ORGOVYX at the time of enrollment or within 1 month prior to enrollment and who remain on treatment at enrollment
Patients who are willing and able to complete PRO assessments during the study
Patients who have reviewed and signed the informed consent form (ICF)
Exclusion Criteria:
Patients with a history of surgical castration
Patients with a medical or psychiatric condition that precludes participation in the opinion of the treating physician
Patients whose original treatment plan is intended to be less than a total of 4 months of ORGOVYX
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 24 Locations for this study
Tucson Arizona, 85704, United States
Little Rock Arkansas, 72211, United States
Stamford Connecticut, 06902, United States
Bradenton Florida, 34205, United States
Tampa Florida, 33607, United States
Arlington Heights Illinois, 60005, United States
Evanston Illinois, 60208, United States
Lake Barrington Illinois, 60010, United States
Carmel Indiana, 46032, United States
Merrillville Indiana, 46410, United States
Wichita Kansas, 67226, United States
Baltimore Maryland, 21204, United States
Syracuse New York, 95054, United States
Charlotte North Carolina, 28210, United States
Beavercreek Ohio, 45431, United States
Gahanna Ohio, 43230, United States
Toledo Ohio, 43606, United States
Myrtle Beach South Carolina, 29572, United States
Houston Texas, 77027, United States
Houston Texas, 77042, United States
San Antonio Texas, 78240, United States
Alexandria Virginia, 22311, United States
Virginia Beach Virginia, 23462, United States
Spokane Washington, 99202, United States
How clear is this clinincal trial information?